XML 60 R46.htm IDEA: XBRL DOCUMENT v3.19.1
Quarterly Selected Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2018
Quarterly Financial Data [Abstract]  
Schedule of Quarterly Financial Information

The operating results for any period are not necessarily indicative of results for any future periods.

 

    Year Ended December 31, 2018  
    1st Quarter     2nd Quarter     3rd Quarter     4th Quarter  
                         
Revenues:                                
Products   $ 9,898,000     $ 10,784,000     $ 9,044,000     $ 7,171,000  
Services     3,481,000       4,025,000       4,341,000       4,320,000  
                                 
      13,379,000       14,809,000       13,385,000       11,491,000  
                                 
Cost of revenues:                                
Cost of products     5,842,000       7,408,000       5,287,000       4,101,000  
Cost of services     1,075,000       986,000       1,301,000       1,266,000  
                                 
      6,917,000       8,394,000       6,588,000       5,367,000  
                                 
Gross Profit     6,462,000       6,415,000       6,797,000       6,124,000  
                                 
Selling, general and administrative expenses     5,696,000       5,993,000       5,921,000       7,061,000  
Research and development expenses     1,743,000       1,542,000       1,696,000       1,882,000  
Other income, net     (13,000 )     4,000       (77,000 )     10,000  
                                 
Net loss   $ (990,000 )   $ (1,116,000 )   $ (897,000 )   $ (2,809,000 )
                                 
Net loss per share - basic and diluted   $ (0.06 )   $ (0.07 )   $ (0.05 )   $ (0.16 )

 

    Year Ended December 31, 2017  
    1st Quarter     2nd Quarter     3rd Quarter     4th Quarter  
                         
Revenues:                                
Products   $ 4,334,000     $ 6,375,000     $ 6,490,000     $ 6,353,000  
Services     3,665,000       4,331,000       4,596,000       4,814,000  
                                 
      7,999,000       10,706,000       11,086,000       11,167,000  
                                 
Cost of revenues:                                
Cost of products     2,815,000       3,427,000       3,475,000       3,736,000  
Cost of services     1,034,000       1,738,000       1,984,000       1,822,000  
                                 
      3,849,000       5,165,000       5,459,000       5,558,000  
                                 
Gross Profit     4,150,000       5,541,000       5,627,000       5,609,000  
                                 
Selling, general and administrative expenses     4,653,000       5,046,000       5,063,000       5,718,000  
Research and development expenses     1,367,000       997,000       1,108,000       1,066,000  
Other income, net     (16,000 )     (22,000 )     (42,000 )     (10,000 )
                                 
Net loss before income tax benefit     (1,886,000 )     (524,000 )     (586,000 )     (1,185,000 )
                                 
Income tax benefit - sale of NJ R&D tax credits     -       -       -       311,000  
                                 
Net loss   $ (1,886,000 )   $ (524,000 )   $ (586,000 )   $ (874,000 )
                                 
Net loss per share - basic and diluted   $ (0.14 )   $ (0.04 )   $ (0.04 )   $ (0.05 )